manufacturer's instructions (TAKARA Co., China). qRT-PCR was performed using the SybrGreen 185 reaction mix and a Light480 sequence detection system (ROCHE Int., Germany). For all of the 186 qRT-PCR reactions, GAPDH was measured as an internal control. All the primer sequences 187 (Invitrogen Int., USA) are listed in Table 3 . All of the PCR products were separated on an 188 ethidium bromide-stained 1.5% agarose gel and visualized with UV. 189
190
Immunohistochemistry (IHC) Immunohistochemistry were performed using gastric cancer 191 paraffin-embedded sections and P-glycoprotein antibody as previously described [20] . 
232
Western blotting analysis Equal amounts of total protein were separated by SDS-PAGE (10% gel) 233 and transferred to nitrocellulose membranes (Bio-Rad) using an Electro-transfer unit (Bio-Rad). 234
The membranes were blocked with 5% nonfat dry milk and 0.1% Tween-20 in TBS and then 235 incubated with the primary antibodies overnight at 4 C following incubation with an 236 HRP-conjugated sheep anti-mouse IgG antibody. The membranes were scanned and analyzed 237 using a Bio-Rad ChemiDoc XRS+ imaging system with imaging software (version quantity 1). All 238 the antibodies used in western blot assay are listed in Table 4 . . Thus, we first determined whether lncRNA dysregulation is directly associated with 274 GC multidrug resistance. SGC7901/ADR and SGC7901/VCR are GC MDR cell sublines derived 275 from the GC cell line, SGC7901, using chemotherapy drugs Adriamycin (ADR) and vincristine 276 (VCR), respectively (Fig. 1A) . In this study, we identified potential lncRNAs involved in GC 277
MDR by analyzing the lncRNA expression profiles of SGC7901/ADR, SGC7901/VCR, and 278 SGC7901 cells using microarrays (Fig. 1B) . The differentially expressed lncRNAs between the 279 MDR sublines and SGC7901 were subsequently further studied. As shown in Figure 1B 
295
MRUL expression levels were negatively correlated with chemosensitivity of gastric cancer cells 296 to P-gp-related chemotherapy drugs. As shown in Figure 1C , MRUL was up-regulated in two GC 297 MDR sublines, as determined using RT-PCR ( Fig. 2A ). To assess a potential role of MRUL in GC 298 tissues, 40 primary GC tissues and paired non-cancerous gastric mucosa samples were obtained 299 from phase IV patients (Table 5 ) who had received no chemotherapy and who underwent 300 palliative operations. As shown in Figure 2B -a, in 25% (6/40) of GC tissues, MRUL expression 301 levels were markedly down-regulated, while in 67.5% levels were significantly up-regulated 302 compared with normal gastric mucosa. In addition, MRUL expression was positively correlated 303 with P-gp expression (Fig. 2B-b, P<0.01) . To evaluate the relationship between MRUL expression 304 level and chemosensitivity of GC tissues, we then performed histoculture drug response assays 305 (HDRAs) using surgically resected GC specimens. The HDRA is a robust method to assess the 306 sensitivity of tumor specimens to chemotherapy drugs in vitro [26, 27] . Forty GC specimens were 307 divided into high and low MRUL expression groups according to the change-fold median (median 308 = 2.20) (Fig. 2C) . Inhibition rates of the two groups were then examined in the presence of ADR 309 using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay. As shown 310
in Figure 2D , the inhibition rate (IR) of the low MRUL expression group was markedly higher 311 than that of the high MRUL expression group (P<0.001). We further demonstrated that IR was 312 negatively correlated with MRUL expression level (P<0.01, Fig. 2E ). In addition, the low MRUL 313 expression group exhibited a significantly higher chemosensitivity frequency (16/20), i.e., being 314 above the IR threshold (30%), compared with the high expression group ( 
cycles). 317
Docetaxol and ADR are P-gp-related chemotherapy drugs. As shown in Figure 2F , the survival 318 time of the low MRUL expression group was significantly longer compared with that of the high 319 expression group (P<0.01). These results suggested that MRUL expression levels were negatively 320 correlated with chemosensitivity of gastric cancer tissues to P-gp-related chemotherapy drugs. 321 322 323 MRUL depletion increases chemosensitivity of MDR GC cell sublines to P-gp-related 324
chemotherapy drugs 325
To investigate the effect of MRUL depletion on the chemosensitivity of MDR GC sublines to 326 P-gp-related chemotherapy drugs, such as ADR or VCR, which can be pumped out of cells by 327 P-gp, MRUL expression was knocked down in SGC7901/ADR and SGC7901/VCR cells using 328 siRNA (Fig. 3A) . MRUL knockdown significantly reduced survival rates of SGC7901/ADR and 329 SGC7901/VCR cells in the presence of ADR (Fig. 3B-a) or VCR (Fig. 3B-b) , but not in the 330 presence of non-P-gp-related chemotherapy drugs, cisplatin (CDDP) (Fig. 3C-a) or 5-fluorouracil 331 (5-FU) (Fig. 3C-b) , in a concentration-dependent manner compared with siRNA negative control 332 (siNC) groups. Moreover, plating colony formation rates of siMRUL groups treated with ADR and 333 VCR were remarkably lower compared with those of siNC groups (Fig. 3D) in siMRUL-SGC7901/ADR and SGC7901/VCR cells compared with siNC groups (Fig. 3E) . Here, In MRUL-depleted SGC7901/ADR and SGC7901/VCR cells, levels of RPS13 and RPL23 358 were markedly decreased, while JNK 1 and CPP32 levels were significantly increased (Fig. 4C) . 359
These data suggested that MRUL depletion might promote ADR-induced apoptosis by increasing 360 ADR accumulation and reducing the Bcl-2/Bax ratio. 361
362

MRUL knockdown reduces ABCB1 expression in vitro and in vivo 363
ADR is a chemotherapeutic agent that can bind to and be pumped out of cells by P-gp. As shown 364 in Figure 4 , MRUL depletion markedly augmented ADR accumulation in SGC7901/ADR and 365 SGC7901/VCR cells. Therefore, we next investigated whether MRUL knockdown could decrease 366 ABCB1 expression in these cells. As shown in Figure 5A , MRUL depletion significantly reduced 367 P-gp protein levels in SGC7901/ADR and SGC7901/VCR cells, and also decreased ABCB1 368 mRNA levels in an siMRUL concentration and time-dependent manner (Fig. 5B-C) . Moreover, 369 SGC7901/ADR cells transfected with lentivirus vectors-MRUL injected into both hind limbs of 370 nude mice showed that MRUL depletion in vitro resulted in MRUL knockdown in vivo (data not 371 shown). However, MRUL over-expression in SGC7901/ADR cells did not significantly 372 up-regulate ABCB1 mRNA levels (Fig. 5D ). In addition, P-gp depletion had no effect on MRUL 373 expression levels at different siP-gp concentrations or with time ( Fig. 5E-F) . We also 374 demonstrated that MRUL depletion significantly reduced GRM3 expression, but did not alter 375 ABCB4, CROT or KIAA1324L expression (data not shown). These data indicated that MRUL 376 down-regulation, and not up-regulation, significantly inhibit P-gp expression. (Fig. 6A) . As aforementioned, silencing of MRUL significantly reduced P-gp mRNA levels, which 383 suggested that MRUL might play an enhancer-like role to regulate ABCB1 transcription. This 384 hypothesis was investigated by performing luciferase assays, because cis-activating enhancers can 385 stimulate transcription when placed adjacent to a heterologous promoter [19] . We demonstrated 386 that the MRUL cDNA (data not shown) significantly increased luciferase transcription compared 387 with pGL4.24-minP-control and pGL4.24-minP vectors (Fig. 6C) . We also found that MRUL 388 knockdown resulted in a partial abolishment of transcriptional enhancement (Fig. 6D) . In addition, 389 reversal (RV) of the MRUL sequence in the reporter construct (data not shown) showed that 390 MRUL exerted its effect in an orientation-independent manner (Fig. 6E) 
. Insertion of MRUL or 391
MRUL-RV (data not shown) downstream of minP in the pGL4.24-minP-luc2P reporter vector did 392 not significantly change transcriptional enhancement (Fig. 6F) , indicating that the enhancing 393 activity of MRUL was position-independent. These data suggested that MRUL exerts an 394 enhancer-like role in regulating ABCB1 expression. 395
Discussion 397
Tumor MDR can only be fully understood by elucidating the underlying MDR mechanisms. 398
Previous studies have demonstrated that tumor MDR resistance involves aberrant protein 399 expression, including for P-gp, which has been extensively studied [5] , [35] . 400 
